• Popular
    • Medicine
    • Radiology
    • Cardiology
    • Surgery
    • Nanomedicine
    • Military Medicine
    • Rehab
  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS
  • Submit PR
  • Log in
Medgadget
Medgadget
  • Popular
    • Medicine
      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

      Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

      Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

      CRISPR Combined with Glowing Proteins for Viral Detection

      CRISPR Combined with Glowing Proteins for Viral Detection

      Biomimetic Construct Models Burn Injuries

      Biomimetic Construct Models Burn Injuries

    • Radiology
      Imaging Technique Reveals Contraction Patterns During Labor

      Imaging Technique Reveals Contraction Patterns During Labor

      Moving Cells Using Ultrasound

      Moving Cells Using Ultrasound

      Ultrasound Catheter to Treat Hypertension

      Ultrasound Catheter to Treat Hypertension

      Antibacterial Smart Sutures Visible in CT Scans

      Antibacterial Smart Sutures Visible in CT Scans

    • Cardiology
      Scientists Grow Electrodes Inside The Body

      Scientists Grow Electrodes Inside The Body

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Patient-Specific Soft Robotic Heart Replicas for Treatment Planning

      Tiny Patch for Cardiac Ultrasound Imaging

      Tiny Patch for Cardiac Ultrasound Imaging

      Belt Monitors Heart Failure Patients

      Belt Monitors Heart Failure Patients

    • Surgery
      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

      Biomimetic Construct Models Burn Injuries

      Biomimetic Construct Models Burn Injuries

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

      Self-Assembling Peptides as a Bioink

      Self-Assembling Peptides as a Bioink

    • Nanomedicine
      Nanoparticles Get Lymphatic Vessels Pumping

      Nanoparticles Get Lymphatic Vessels Pumping

      Bottlebrush Particle for Synergistic Drug Combinations

      Bottlebrush Particle for Synergistic Drug Combinations

      Extra Hot Nanoparticles for Cancer Therapy

      Extra Hot Nanoparticles for Cancer Therapy

      Making Tumors Tastier for the Immune System

      Making Tumors Tastier for the Immune System

    • Military Medicine
      Device Measures Hemoglobin More Accurately in Dark Skin

      Device Measures Hemoglobin More Accurately in Dark Skin

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fingertip Sensor Measures Lithium Levels in Sweat

      Fabric Makes Electricity from Movement to Power Wearables

      Fabric Makes Electricity from Movement to Power Wearables

      Wearable Uses Microneedles to Track Metabolism

      Wearable Uses Microneedles to Track Metabolism

    • Rehab
      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

      Smart Walking Stick for Visually Impaired People

      Smart Walking Stick for Visually Impaired People

      Implantable Device Adheres to Muscle, Treats Atrophy

      Implantable Device Adheres to Muscle, Treats Atrophy

      Non-Invasive Spinal Modulation for Cerebral Palsy

      Non-Invasive Spinal Modulation for Cerebral Palsy

  • Categories
    • Exclusive
    • A-D
      • Anesthesiology
      • Art
      • Cardiac Surgery
      • Cardiology
      • Critical Care
      • Dentistry
      • Dermatology
      • Diagnostics
    • E-I
      • Emergency Medicine
      • ENT
      • Genetics
      • Geriatrics
      • GI
      • Informatics
    • M-N
      • Medicine
      • Military Medicine
      • Nanomedicine
      • Net News
      • Neurology
      • Neurosurgery
      • Nuclear Medicine
    • O-P
      • Ob/Gyn
      • Oncology
      • Ophthalmology
      • Orthopedic Surgery
      • Pathology
      • Pediatrics
      • Plastic Surgery
      • Psychiatry
      • Public Health
    • R-V
      • Radiation Oncology
      • Radiology
      • Rehab
      • Reproductive Medicine
      • Space Medicine
      • Sports Medicine
      • Surgery
      • Thoracic Surgery
      • Urology
      • Vascular Surgery
  • SUBSCRIBE
  • Submit PR
  • About
  • Log in
  • Submit PR
  • Follow
    • Facebook
    • Twitter
    • Linkedin
    • Youtube
    • Instagram
    • RSS

Spinal Cord Injury Market to Grow at a Substantial Growth Rate During the Forecast Period (2022-2032) – DelveInsight | Key Companies – Abbvie, Lineage Cell Therapeutics, KAI Pharmaceuticals, Eli Lilly and Company, Ferrer Internacional S.A

February 7th, 2023 DelveInsight Business Research LLP Releases

The Spinal Cord Injury market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Spinal Cord Injury pipeline products will significantly revolutionize the Spinal Cord Injury market dynamics.  

DelveInsight’s “Spinal Cord Injury Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Spinal Cord Injury, historical and forecasted epidemiology as well as the Spinal Cord Injury market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Spinal Cord Injury market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

To Know in detail about the Spinal Cord Injury market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Spinal Cord Injury Market Insights

Spinal Cord Injury Overview

Spinal cord injury (SCI) is a serious medical condition that causes functional, psychological, and socioeconomic disorders. Long-term, secondary medical complications are common and play an important role in the continuum of care for patients with SCI. Complications are a frequent cause of morbidity and mortality and lead to increased rates of re-hospitalization, loss of employability, and decreased quality of life. The most common cause of spinal cord injury is trauma. Nearly half of the injuries are caused by motor vehicle accidents. Other types of trauma include: falls from height, violence (stabbing or gunshot wounds to the spine), and sporting injuries (diving, football, rugby, equestrian, etc.).

Some of the key facts of the Spinal Cord Injury Market Report: 

  • The Spinal Cord Injury market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
  • The incidence of Spinal Cord Injury in the rest of the world is much lower than in the United States. There are several possible explanations for this. One is the relative absence in most countries of Spinal Cord Injury because of acts of violence
  • The total diagnosed cases of Spinal Cord Injury in the 7MM was estimated to be 722,217 cases in 2021, which is expected to increase in the forecast period (2022-2032)
  • Among the 7MM countries, the United States had the highest diagnosed cases of Spinal Cord Injury followed by Japan, Germany and Italy in 2021. On the other hand, Spain had the lowest diagnosed cases
  • Among the European five countries, Germany had the 80,850 cases which is highest, followed by Italy in 2021. On the other hand, Spain had the lowest diagnosed cases
  • Key Spinal Cord Injury Companies: Athersys, Kancera, AlaMab therapeutics, ReNetX Bio, Histocell, Lineage Cell Therapeutics, Eli Lilly and Company, Ferrer Internacional S.A, AbbVie, Mitsubishi Tanabe Pharma, Pharmazz, Eusol Biotech, Kringle Pharma, and others
  • Key Spinal Cord Injury Therapies: EAllogeneic stem cell therapy, KAND 567, ALMB0166, AXER-204, FAB117-HC, AST-OPC1, Elezanumab, AST-OPC1, MT 3921, PMZ-1620, ES 135, KP-100IT, and others
  • The Spinal Cord Injury epidemiology based on gender analyzed that Males are affected more as compared to females, in case of Spinal Cord Injury

Get a Free sample for the Spinal Cord Injury Market Report

Key benefits of the Spinal Cord Injury Market report:

  1. Spinal Cord Injury market report covers a descriptive overview and comprehensive insight of the Spinal Cord Injury Epidemiology and Spinal Cord Injury market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
  2. The Spinal Cord Injury market report provides insights on the current and emerging therapies.
  3. Spinal Cord Injury market report provides a global historical and forecasted market covering drug outreach in 7MM.
  4. The Spinal Cord Injury market report offers an edge that will help develop business strategies by understanding trends shaping and driving the Spinal Cord Injury market.

Download the report to understand which factors are driving Spinal Cord Injury epidemiology trends @ Spinal Cord Injury Epidemiological Insights 

Spinal Cord Injury Market  

The dynamics of the Spinal Cord Injury market are anticipated to change in the coming years owing to the expected launch of emerging therapies and others during the forecasted period 2019-2032.  

Spinal Cord Injury Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Spinal Cord Injury Epidemiology Segmentation:

The Spinal Cord Injury market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Total Prevalence of Spinal Cord Injury
  • Prevalent Cases of Spinal Cord Injury by severity
  • Gender-specific Prevalence of Spinal Cord Injury
  • Diagnosed Cases of Episodic and Chronic Spinal Cord Injury

Spinal Cord Injury Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Spinal Cord Injury market or expected to get launched during the study period. The analysis covers Spinal Cord Injury market uptake by drugs, patient uptake by therapies, and sales of each drug.  

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Spinal Cord Injury Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Discover more about therapies set to grab major Spinal Cord Injury market share @ Spinal Cord Injury market forecast 

Spinal Cord Injury Therapies and Key Companies

  • Elezanumab (ABT-555): Abbvie
  • AST-OPC1: Lineage Cell Therapeutics  
  • Elezanumab: Abbvie
  • KAI-1678: KAI Pharmaceuticals
  • Tadalafil: Eli Lilly and Company
  •  FAB117-HC: Ferrer Internacional S.A

Spinal Cord Injury Market Drivers

  • New approaches for therapy development
  • Establishment of specialized care centers
  • Absence of approved therapy
  • Rise in Cases

Scope of the Spinal Cord Injury Market Report

  • Study Period: 2019–2032
  • Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
  • Key Spinal Cord Injury Companies: Athersys, Kancera, AlaMab therapeutics, ReNetX Bio, Histocell, Lineage Cell Therapeutics, Eli Lilly and Company, Ferrer Internacional S.A, AbbVie, Mitsubishi Tanabe Pharma, Pharmazz, Eusol Biotech, Kringle Pharma, and others
  • Key Spinal Cord Injury Therapies: Allogeneic stem cell therapy, KAND 567, ALMB0166, AXER-204, FAB117-HC, AST-OPC1, Elezanumab, AST-OPC1, MT 3921, PMZ-1620, ES 135, KP-100IT, and others
  • Spinal Cord Injury Therapeutic Assessment: Spinal Cord Injury current marketed and Spinal Cord Injury emerging therapies
  • Spinal Cord Injury Market Dynamics:  Spinal Cord Injury market drivers and Spinal Cord Injury market barriers 
  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
  • Spinal Cord Injury Unmet Needs, KOL’s views, Analyst’s views, Spinal Cord Injury Market Access and Reimbursement 

Spinal Cord Injury Market Barriers

  • Hurdles associated with gathering preclinical data
  • Demographic variations in Spinal Cord Injury incidence
  • Ethical concerns associated with stem cell therapies

Table of Contents 

  1. Spinal Cord Injury Market Report Introduction
  2. Executive Summary for Spinal Cord Injury
  3. SWOT analysis of Spinal Cord Injury
  4. Spinal Cord Injury Patient Share (%) Overview at a Glance
  5. Spinal Cord Injury Market Overview at a Glance
  6. Spinal Cord Injury Disease Background and Overview
  7. Spinal Cord Injury Epidemiology and Patient Population
  8. Country-Specific Patient Population of Spinal Cord Injury 
  9. Spinal Cord Injury Current Treatment and Medical Practices
  10. Spinal Cord Injury Unmet Needs
  11. Spinal Cord Injury Emerging Therapies
  12. Spinal Cord Injury Market Outlook
  13. Country-Wise Spinal Cord Injury Market Analysis (2019–2032)
  14. Spinal Cord Injury Market Access and Reimbursement of Therapies
  15. Spinal Cord Injury Market Drivers
  16. Spinal Cord Injury Market Barriers
  17. Spinal Cord Injury Appendix
  18. Spinal Cord Injury Report Methodology
  19. DelveInsight Capabilities
  20. Disclaimer
  21. About DelveInsight

To know more about Spinal Cord Injury treatment, visit @ Spinal Cord Injury Medications 

Related Reports: 

Spinal Cord Injury Pipeline  

“Spinal Cord Injury Pipeline Insight, 2023” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Spinal Cord Injury market. A detailed picture of the Spinal Cord Injury pipeline landscape is provided, which includes the disease overview and Spinal Cord Injury treatment guidelines. 

Spinal Cord Injury Epidemiology 

DelveInsight’s ‘Spinal Cord Injury Epidemiology Forecast to 2032‘ report delivers an in-depth understanding of the disease, historical and forecasted Spinal Cord Injury epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. 

Latest Reports by DelveInsight

Hypertrophic Scar Market | Lung Fibrosis Market | Anterior Uveitis Market | 22q11.2 deletion syndrome Market | X-Linked Retinitis Pigmentosa (XLRP) Market | Acute Radiation Syndrome Market | Alpha-1 Protease Inhibitor Deficiency Market | Androgenetic Alopecia Market | Hyperlipidemia Market | Cardiotoxicity Market | Hypertrophic Cardiomyopathy Market | Fatty Acid Oxidation Disorders (FAODs) Market | Androgen Insensitivity Syndrome Market | Emphysema Market | Canaloplasty Market | Dravet Syndrome Market | Celiac Disease Market | Chlamydia Infections Market | Syphilis Market | Renal Tubular Acidosis Market | Palmoplantar Pustulosis (PPP) Market | Aplastic Anemia Market | Bacterial Pneumonia Market | B cell Chronic Lymphocytic Leukemia Market | B cell Lymphomas Market | Behcets Disease Market Neoantigen-based Personalized Cancer therapeutic Vaccines Competitive Landscape and Market Forecast—by 2035 | Glioblastoma Market

Recent Blog’s By DelveInsight:

  • Insights Into The Cutaneous T-cell Lymphoma Treatment Market
  • Roche’s HEMLIBRA: A Game Changer in Hemophilia A Treatment Landscape
  • Emerging Role of Digital Health in the Field of Oncology
  • How Will Emerging Therapies Drift the Amyotrophic Lateral Sclerosis (ALS) Treatment Landscape
  • How are Technological Trends and Innovations Reshaping the Dementia Care
  • Assessing the Major Growth and Ongoing Developments in the Clinical Diagnostics Market
  • Non-opioid Analgesics Chronic Pain Treatment: Savior of Underserved Patients
  • Limited Availability and Lack of Access are Unlikely to Hinder the Billion-Dollar Alpha-1 Antitrypsin Deficiency (AATD) Treatment Market
  • Evaluating the Key Trends and Technologies Shaping the Future of Dentistry

About DelveInsight 

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact 

Company Name: DelveInsight Business Research LLP

Contact Person: Gaurav Bora

Email: info@delveinsight.com

City: Albany

State: New York

Country: United States

Website: https://www.delveinsight.com/consulting 

Sign up and submit a press release

Sponsored
Venture builder BHV Partners launches Conus Airway to improve anaesthesia  and respiratory surgery

Venture builder BHV Partners launches Conus Airway to improve anaesthesia and respiratory surgery

FDA Expands Indications for Use of FibroScan® for Comprehensive Liver Management

FDA Expands Indications for Use of FibroScan® for Comprehensive Liver Management

machineMD and Varjo revolutionize the diagnosis of brain disorders with a VR-based eye-tracking solution 

machineMD and Varjo revolutionize the diagnosis of brain disorders with a VR-based eye-tracking solution 

Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Ax-Surgi Hemostat gets FDA Clearance for Surgical Bleeding Control

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

Clarius Report Finds 85% of Clinicians Believe Ultrasound Leads to Better Patient Outcomes

interviews & reviews
Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Levels Is Making Metabolism and Blood Glucose Tracking Accessible To Everyone

Imagene Profiles Cancer Biomarkers in Real Time

Imagene Profiles Cancer Biomarkers in Real Time

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Empowering Stroke Survivors: Interview with Kirsten Carroll, CEO at Kandu Health

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Alpha TAU Killing Tumors With Highly Targeted Alpha Radiation

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Neuroimmune Modulation for Inflammatory Disease: Interview with Dr. Simhambhatla, President and CEO of SetPoint Medical

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Exclusive Look at HandX Robotic-Assisted Surgical Device from Human Xtensions

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

Balance Boards to Stay Active in the Offfice: Interview with Joel Heath, CEO of FluidStance 

  • Subscribe
  • Contact us
  • Submit
  • About
  • Back to top
Medgadget

Medical technologies transform the world! Join us and see the progress in real time. At Medgadget, we report the latest technology news, interview leaders in the field, and file dispatches from medical events around the world since 2004.

  • About
  • Editorial policies
  • Contact
  • Terms of Service
  • Privacy
  • Submit press release
  • Advertise
© Medgadget, Inc. All rights reserved. | The Medical Revolution Will Be Blogged.
Please support this website by adding us to your whitelist in your ad blocker. Ads are what helps us bring you premium content! Thank you!
  • Facebook
  • Twitter
  • LinkedIn
  • Reddit
  • Email